- Latest available (Revised)
- Original (As made)
The Medicines (Products for Human Use — Fees) Regulations 1995
You are here:
- 1995 No. 1116
- SCHEDULE 1
- PART III
- Regulation 14
What Version
Status:
This is the original version (as it was originally made). UK Statutory Instruments are not carried in their revised form on this site.
Identical variations
14. Where more than one application for a Type II complex variation is made at the same time by the same applicant for the variation of a marketing authorization, the fee payable under regulation 7(1)
(a)in connection with the first application considered by the licensing authority shall be the appropriate amount specified in this Part of the Schedule;
(b)in connection with each of the other applications where the applications are for identical variations and in respect of which no further medical, scientific or pharmaceutical assessment is required shall be the amount which would be payable if the application was a Type II Application.
Options/Help
Print Options
Print The Whole Instrument
Print The Whole Schedule
Print The Whole Part
Print This Section only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Opening Options
Different options to open legislation in order to view more content on screen at once